The inflammatory microenvironment and microbiome in prostate cancer development

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review

Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155

Safety, activity, and immune correlates of anti–PD-1 antibody in cancer

Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628

Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., Ready, N. E., Chow, L. Q., Vokes, E. E., Felip, E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507643 · Cited by 9,335

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Brahmer, J., Reckamp, K. L., Baas, P., Crinò, L., Eberhardt, W. E. E., Poddubskaya, E., Antonia, S., Pluzanski, A., Vokes, E. E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504627 · Cited by 8,447

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Robert, C., Schachter, J., Long, G. V., Arance, A., Grob, J. J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503093 · Cited by 5,887

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572

Nivolumab in Previously Untreated Melanoma without BRAF Mutation

Robert, C., Long, G. V., Brady, B., Dutriaux, C., Maio, M., Mortier, L., Hassel, J. C., Rutkowski, P., McNeil, C., Kalinka-Warzocha, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412082 · Cited by 5,519

The immune contexture in human tumours: impact on clinical outcome

Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy

Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488

Intestinal epithelial cells: regulators of barrier function and immune homeostasis

Peterson, L. W., & Artis, D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3608 · Cited by 3,173

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Brahmer, J. R., Drake, C. G., Wollner, I., Powderly, J. D., Picus, J., Sharfman, W. H., Stankevich, E., Pons, A., Salay, T. M., McMiller, T. L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7609 · Cited by 2,961

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

Weber, J. S., D'Angelo, S. P., Minor, D., Hodi, F. S., Gutzmer, R., Neyns, B., Hoeller, C., Khushalani, N. I., Miller, W. H., Lao, C. D., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70076-8 · Cited by 2,676

Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment

Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., et al. (2013) · Science · doi:10.1126/science.1240527 · Cited by 2,251

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057

The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., et al. (2013) · Science · doi:10.1126/science.1240537 · Cited by 2,050

Inflammation in prostate carcinogenesis

De Marzo, A. M., Platz, E. A., Sutcliffe, S., Xu, J., Grönberg, H., Drake, C. G., Nakai, Y., Isaacs, W. B., & Nelson, W. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2090 · Cited by 1,621

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

Kwon, E. D., Drake, C. G., Scher, H. I., Fizazi, K., Bossi, A., van den Eertwegh, A. J. M., Krainer, M., Houede, N., Santos, R., Mahammedi, H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70189-5 · Cited by 1,511

Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours

Galon, J., Mlecnik, B., Bindea, G., Angell, H. K., Berger, A., Lagorce, C., Lugli, A., Zlobec, I., Hartmann, A., Bifulco, C., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4287 · Cited by 1,360

BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.6961 · Cited by 1,252

Prostate Cancer

Nelson, W. G., De Marzo, A. M., & Isaacs, W. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021562 · Cited by 918

Proliferative Inflammatory Atrophy of the Prostate

De Marzo, A. M., Marchi, V. L., Epstein, J. I., & Nelson, W. G. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65517-4 · Cited by 872

Urine Is Not Sterile: Use of Enhanced Urine Culture Techniques To Detect Resident Bacterial Flora in the Adult Female Bladder

Hilt, E. E., McKinley, K., Pearce, M. M., Rosenfeld, A. B., Zilliox, M. J., Mueller, E. R., Brubaker, L., Gai, X., Wolfe, A. J., & Schreckenberger, P. C. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02876-13 · Cited by 860

Integrated data from 2 randomized, double‐blind, placebo‐controlled, phase 3 trials of active cellular immunotherapy with sipuleucel‐T in advanced prostate cancer

Higano, C. S., Schellhammer, P. F., Small, E. J., Burch, P. A., Nemunaitis, J., Yuh, L., Provost, N., & Frohlich, M. W. (2009) · Cancer · doi:10.1002/cncr.24429 · Cited by 810

Cancer classification using the Immunoscore: a worldwide task force

Galon, J., Pagès, F., Marincola, F. M., Angell, H. K., Thurin, M., Lugli, A., Zlobec, I., Berger, A., Bifulco, C., Botti, G., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-205 · Cited by 791

Immunomodulatory mast cells: negative, as well as positive, regulators of immunity

Galli, S. J., Grimbaldeston, M., & Tsai, M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2327 · Cited by 738

Regulatory T cells in cancer

Beyer, M., & Schultze, J. L. (2006) · Blood · doi:10.1182/blood-2006-02-002774 · Cited by 732

The Female Urinary Microbiome: a Comparison of Women with and without Urgency Urinary Incontinence

Pearce, M. M., Hilt, E. E., Rosenfeld, A. B., Zilliox, M. J., Thomas-White, K., Fok, C., Kliethermes, S., Schreckenberger, P. C., Brubaker, L., Gai, X., et al. (2014) · mBio · doi:10.1128/mbio.01283-14 · Cited by 725

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

Ammirante, M., Luo, J.-L., Grivennikov, S., Nedospasov, S., & Karin, M. (2010) · Nature · doi:10.1038/nature08782 · Cited by 639

The microbiome of the urinary tract—a role beyond infection

Whiteside, S. A., Razvi, H., Dave, S., Reid, G., & Burton, J. P. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2014.361 · Cited by 633

Epithelial Barriers in Homeostasis and Disease

Marchiando, A. M., Graham, W. V., & Turner, J. R. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092135 · Cited by 613

Prostate cancer and inflammation: the evidence

Sfanos, K. S., & De Marzo, A. M. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04033.x · Cited by 612

Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements

Haffner, M. C., Aryee, M. J., Toubaji, A., Esopi, D. M., Albadine, R., Gurel, B., Isaacs, W. B., Bova, G. S., Liu, W., Xu, J., et al. (2010) · Nature Genetics · doi:10.1038/ng.613 · Cited by 608

Oxidative Damage Targets Complexes Containing DNA Methyltransferases, SIRT1, and Polycomb Members to Promoter CpG Islands

O'Hagan, H. M., Wang, W., Sen, S., DeStefano Shields, C., Lee, S. S., Zhang, Y. W., Clements, E. G., Cai, Y., Van Neste, L., Easwaran, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.012 · Cited by 563

Multiple roles for CD4+ T cells in anti‐tumor immune responses

Kennedy, R., & Celis, E. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00616.x · Cited by 511

Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury

Fouts, D. E., Pieper, R., Szpakowski, S., Pohl, H., Knoblach, S., Suh, M.-J., Huang, S.-T., Ljungberg, I., Sprague, B. M., Lucas, S. K., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-174 · Cited by 474

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis

Gurel, B., Iwata, T., M Koh, C., Jenkins, R. B., Lan, F., Van Dang, C., Hicks, J. L., Morgan, J., Cornish, T. C., Sutcliffe, S., et al. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.111 · Cited by 441

Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing

Sfanos, K. S., Bruno, T. C., Maris, C. H., Xu, L., Thoburn, C. J., DeMarzo, A. M., Meeker, A. K., Isaacs, W. B., & Drake, C. G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5164 · Cited by 427

CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients

Miller, A. M., Lundberg, K., Özenci, V., Banham, A. H., Hellström, M., Egevad, L., & Pisa, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7398 · Cited by 421

Epidemiologic association between prostatitis and prostate cancer

Dennis, L. K., Lynch, C. F., & Torner, J. C. (2002) · Urology · doi:10.1016/s0090-4295(02)01637-0 · Cited by 403

Prostate carcinogenesis and inflammation: emerging insights

Palapattu, G. S., Sutcliffe, S., Bastian, P. J., Platz, E. A., De Marzo, A. M., Isaacs, W. B., & Nelson, W. G. (2005) · Carcinogenesis · doi:10.1093/carcin/bgh317 · Cited by 388

Double Strand Breaks Can Initiate Gene Silencing and SIRT1-Dependent Onset of DNA Methylation in an Exogenous Promoter CpG Island

O'Hagan, H. M., Mohammad, H. P., & Baylin, S. B. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000155 · Cited by 386

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

Graff, J. N., Alumkal, J. J., Drake, C. G., Thomas, G. V., Redmond, W. L., Farhad, M., Cetnar, J. P., Ey, F. S., Bergan, R. C., Slottke, R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10547 · Cited by 359

CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer

Kiniwa, Y., Miyahara, Y., Wang, H. Y., Peng, W., Peng, G., Wheeler, T. M., Thompson, T. C., Old, L. J., & Wang, R.-F. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0842 · Cited by 352

Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival.

Lissbrant, I. F., Stattin, P., Wikstrom, P., Damber, J. E., Egevad, L., & Bergh, A. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.3.445 · Cited by 333

Asymptomatic inflammation and/or infection in benign prostatic hyperplasia

Nickel, Downey, Young, & Boag (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00352.x · Cited by 319

MYC and Prostate Cancer

Koh, C. M., Bieberich, C. J., Dang, C. V., Nelson, W. G., Yegnasubramanian, S., & De Marzo, A. M. (2010) · Genes & Cancer · doi:10.1177/1947601910379132 · Cited by 296

DNA Hypomethylation Arises Later in Prostate Cancer Progression than CpG Island Hypermethylation and Contributes to Metastatic Tumor Heterogeneity

Yegnasubramanian, S., Haffner, M. C., Zhang, Y., Gurel, B., Cornish, T. C., Wu, Z., Irizarry, R. A., Morgan, J., Hicks, J., DeWeese, T. L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6088 · Cited by 294

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer

Bishop, J. L., Sio, A., Angeles, A., Roberts, M. E., Azad, A. A., Chi, K. N., & Zoubeidi, A. (2015) · Oncotarget · doi:10.18632/oncotarget.2703 · Cited by 279

DNA Methylation Alterations Exhibit Intraindividual Stability and Interindividual Heterogeneity in Prostate Cancer Metastases

Aryee, M. J., Liu, W., Engelmann, J. C., Nuhn, P., Gurel, M., Haffner, M. C., Esopi, D., Irizarry, R. A., Getzenberg, R. H., Nelson, W. G., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005211 · Cited by 275

Characteristic Male Urine Microbiomes Associate with Asymptomatic Sexually Transmitted Infection

Nelson, D. E., Van Der Pol, B., Dong, Q., Revanna, K. V., Fan, B., Easwaran, S., Sodergren, E., Weinstock, G. M., Diao, L., & Fortenberry, J. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014116 · Cited by 269

Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer

Shrestha, E., White, J. R., Yu, S.-H., Kulac, I., Ertunc, O., De Marzo, A. M., Yegnasubramanian, S., Mangold, L. A., Partin, A. W., & Sfanos, K. S. (2018) · Journal of Urology · doi:10.1016/j.juro.2017.08.001 · Cited by 261

PROPIONIBACTERIUM ACNES ASSOCIATED WITH INFLAMMATION IN RADICAL PROSTATECTOMY SPECIMENS: A POSSIBLE LINK TO CANCER EVOLUTION?

COHEN, R. J., SHANNON, B. A., McNEAL, J. E., SHANNON, T., & GARRETT, K. L. (2005) · Journal of Urology · doi:10.1097/01.ju.0000158161.15277.78 · Cited by 246

Epidemiology of Inflammation and Prostate Cancer

PLATZ, E. A., & De MARZO, A. M. (2004) · Journal of Urology · doi:10.1097/01.ju.0000108131.43160.77 · Cited by 243

Bacterial Communities of the Coronal Sulcus and Distal Urethra of Adolescent Males

Nelson, D. E., Dong, Q., Van Der Pol, B., Toh, E., Fan, B., Katz, B. P., Mi, D., Rong, R., Weinstock, G. M., Sodergren, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036298 · Cited by 242

Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial

Gurel, B., Lucia, M. S., Thompson, I. M., Goodman, P. J., Tangen, C. M., Kristal, A. R., Parnes, H. L., Hoque, A., Lippman, S. M., Sutcliffe, S., et al. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1126 · Cited by 236

The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer

Gevensleben, H., Dietrich, D., Golletz, C., Steiner, S., Jung, M., Thiesler, T., Majores, M., Stein, J., Uhl, B., Müller, S., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2042 · Cited by 235

Human prostate‐infiltrating CD8+ T lymphocytes are oligoclonal and PD‐1+

Sfanos, K. S., Bruno, T. C., Meeker, A. K., De Marzo, A. M., Isaacs, W. B., & Drake, C. G. (2009) · The Prostate · doi:10.1002/pros.21020 · Cited by 233

Impact of Pelvic Radiotherapy on Gut Microbiota of Gynecological Cancer Patients Revealed by Massive Pyrosequencing

Nam, Y.-D., Kim, H. J., Seo, J.-G., Kang, S. W., & Bae, J.-W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082659 · Cited by 230

A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms

Sfanos, K. S., Sauvageot, J., Fedor, H. L., Dick, J. D., De Marzo, A. M., & Isaacs, W. B. (2008) · The Prostate · doi:10.1002/pros.20680 · Cited by 219

The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment

Gottschick, C., Deng, Z.-L., Vital, M., Masur, C., Abels, C., Pieper, D. H., & Wagner-Döbler, I. (2017) · Microbiome · doi:10.1186/s40168-017-0305-3 · Cited by 215

Intermediate Cells in Human Prostate Epithelium Are Enriched in Proliferative Inflammatory Atrophy

van Leenders, G. J. L. H., Gage, W. R., Hicks, J. L., van Balken, B., Aalders, T. W., Schalken, J. A., & De Marzo, A. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64286-1 · Cited by 212

Infiltration of tumour‐associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer

Nonomura, N., Takayama, H., Nakayama, M., Nakai, Y., Kawashima, A., Mukai, M., Nagahara, A., Aozasa, K., & Tsujimura, A. (2011) · BJU International · doi:10.1111/j.1464-410x.2010.09804.x · Cited by 197

Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance

Martin, A. M., Nirschl, T. R., Nirschl, C. J., Francica, B. J., Kochel, C. M., van Bokhoven, A., Meeker, A. K., Lucia, M. S., Anders, R. A., DeMarzo, A. M., et al. (2015) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2015.39 · Cited by 188

Immune Infiltration and Prostate Cancer

Strasner, A., & Karin, M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00128 · Cited by 184

Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin

Kwon, O.-J., Zhang, L., Ittmann, M. M., & Xin, L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318157111 · Cited by 180

Tumor infiltrating B-cells are increased in prostate cancer tissue

Woo, J. R., Liss, M. A., Muldong, M. T., Palazzi, K., Strasner, A., Ammirante, M., Varki, N., Shabaik, A., Howell, S., Kane, C. J., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-30 · Cited by 180

The human urine virome in association with urinary tract infections

Santiago-Rodriguez, T. M., Ly, M., Bonilla, N., & Pride, D. T. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00014 · Cited by 167

Prostate cancer and sexually transmitted diseases: a meta-analysis.

Taylor, M. L., Mainous, A. G., & Wells, B. J. (2005) · PubMed · Cited by 163

Cyclooxygenase-2 Expression Correlates with Local Chronic Inflammation and Tumor Neovascularization in Human Prostate Cancer

Wang, W., Bergh, A. R. J., & Damber, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2405 · Cited by 157

Sexually transmitted infections and prostate cancer risk: A systematic review and meta-analysis

Caini, S., Gandini, S., Dudas, M., Bremer, V., Severi, E., & Gherasim, A. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.06.002 · Cited by 153

Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer

Sfanos, K. S., Wilson, B. A. P., Marzo, A. M. D., & Isaacs, W. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810473106 · Cited by 151

The Role of M1 and M2 Macrophages in Prostate Cancer in relation to Extracapsular Tumor Extension and Biochemical Recurrence after Radical Prostatectomy

Lanciotti, M., Masieri, L., Raspollini, M. R., Minervini, A., Mari, A., Comito, G., Giannoni, E., Carini, M., Chiarugi, P., & Serni, S. (2014) · BioMed Research International · doi:10.1155/2014/486798 · Cited by 146

Prostatitis as a Risk Factor for Prostate Cancer

Roberts, R. O., Bergstralh, E. J., Bass, S. E., Lieber, M. M., & Jacobsen, S. J. (2004) · Epidemiology · doi:10.1097/01.ede.0000101022.38330.7c · Cited by 142

A mouse model of chronic prostatic inflammation using a human prostate cancer‐derived isolate of Propionibacterium acnes

Shinohara, D. B., Vaghasia, A. M., Yu, S., et al. (2013) · The Prostate · doi:10.1002/pros.22648 · Cited by 135

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia

Yu, H., Meng, H., Zhou, F., Ni, X., Shen, S., & Das, U. N. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.50970 · Cited by 133

Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters

Ebelt, K., Babaryka, G., Frankenberger, B., Stief, C. G., Eisenmenger, W., Kirchner, T., Schendel, D. J., & Noeßner, E. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.02.015 · Cited by 128

The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer

McArdle, P., Canna, K., McMillan, D. C., McNicol, A. M., Campbell, R., & Underwood, M. A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601943 · Cited by 124

High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

Flammiger, A., Weisbach, L., Huland, H., Tennstedt, P., Simon, R., Minner, S. J. P., Bokemeyer, C., Sauter, G., Schlomm, T., & Trepel, M. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.11.035 · Cited by 124

Tumour-infiltrating lymphocytes: A prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy.

Kärjä, V. J., Aaltomaa, S. H., Lipponen, P., Isotalo, T., Talja, M. T., & Mokka, R. (2005) · PubMed · Cited by 124

CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3+ regulatory T cells with respect to lethal prostate cancer

Davidsson, S., Ohlson, A., Andersson, S., Fall, K., Meisner, A., Fiorentino, M., Andrén, O., & Rider, J. R. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.164 · Cited by 115

Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome

Liu, X., Grogan, T., Hieronymus, H., Hashimoto, T., Mottahedeh, J., Cheng, D., Zhang, L., Huang, K. Y., Stoyanova, T. I., Park, J. W., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.010 · Cited by 112

Castration influences intestinal microflora and induces abdominal obesity in high-fat diet-fed mice

Harada, N., Hanaoka, R., Horiuchi, H., Kitakaze, T., Mitani, T., Inui, H., & Yamaji, R. (2016) · Scientific Reports · doi:10.1038/srep23001 · Cited by 110

Amyloid Formation by the Pro-Inflammatory S100A8/A9 Proteins in the Ageing Prostate

Yanamandra, K., Alexeyev, O. A., Zamotin, V., Srivastava, V., Shchukarev, A., Brorsson, A., Tartaglia, G. G., Vogl, T., Kayed, R., Wingsle, G., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005562 · Cited by 108

Transcription-Induced DNA Double Strand Breaks: Both Oncogenic Force and Potential Therapeutic Target?

Haffner, M. C., Marzo, A. M. D., Meeker, A. K., Nelson, W. G., & Yegnasubramanian, S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2044 · Cited by 108

Morphological transition of proliferative inflammatory atrophy to high‐grade intraepithelial neoplasia and cancer in human prostate

Wang, W., Bergh, A. R. J., & Damber, J. (2009) · The Prostate · doi:10.1002/pros.20992 · Cited by 108

Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis

Elkahwaji, J. E., Zhong, W., Hopkins, W. J., & BUSHMAN, W. A. (2006) · The Prostate · doi:10.1002/pros.20445 · Cited by 107

High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy

Irani, J., Goujon, J., Ragni, E., Peyrat, L., Hubert, J., Saint, F., & Mottet, N. (1999) · Urology · doi:10.1016/s0090-4295(99)00152-1 · Cited by 107

Experimental rodent models of prostatitis: limitations and potential

Vykhovanets, E. V., Resnick, M. I., MacLennan, G. T., & Gupta, S. (2007) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500930 · Cited by 106

Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer

Davidsson, S., Mölling, P., Rider, J. R., Unemo, M., Karlsson, M. G., Carlsson, J., Andersson, S., Elgh, F., Söderquist, B., & Andrén, O. (2016) · Infectious Agents and Cancer · doi:10.1186/s13027-016-0074-9 · Cited by 106

Assessment of the Lower Urinary Tract Microbiota during Symptom Flare in Women with Urologic Chronic Pelvic Pain Syndrome: A MAPP Network Study

Nickel, J. C., Stephens, A. J., Landis, J. R., Mullins, C., van Bokhoven, A., Lucia, M. S., & Ehrlich, G. D. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.09.075 · Cited by 105

The Role of Inflammation in Prostate Cancer

Sfanos, K. S., Hempel, H., & Marzo, A. M. D. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-0348-0837-8_7 · Cited by 92

Search for Microorganisms in Men with Urologic Chronic Pelvic Pain Syndrome: A Culture-Independent Analysis in the MAPP Research Network

Nickel, J. C., Stephens, A. J., Landis, J. R., Chen, J., Mullins, C. E., van Bokhoven, A., Lucia, M. S., Kreft, R., & Ehrlich, G. D. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.01.037 · Cited by 92

Prostatic structure and function in relation to the etiology of prostatic cancer

Isaacs, J. T. (1983) · The Prostate · doi:10.1002/pros.2990040405 · Cited by 92

Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer

Mani, R. S., Amin, M. A., Li, X., Sundaram, S. K., Veeneman, B. A., Wang, L., Ghosh, A., Aslam, A. J., Ramanand, S. G., Rabquer, B. J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.019 · Cited by 92

Sexually Transmissible Infections and Prostate Cancer Risk

Huang, W., Hayes, R. B., Pfeiffer, R. M., Viscidi, R. P., Lee, F. K., Wang, Y. F., Reding, D. J., Whitby, D., Papp, J. R., & Rabkin, C. S. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0173 · Cited by 90

Decreased microbiota diversity associated with urinary tract infection in a trial of bacterial interference

Horwitz, D., McCue, T., Mapes, A. C., Ajami, N. J., Petrosino, J. F., Ramig, R. F., & Trautner, B. W. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.05.014 · Cited by 89

Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer

Flammiger, A., Bayer, F., Cirugeda‐Kühnert, A., Huland, H., Tennstedt, P., Simon, R., Minner, S. J. P., Bokemeyer, C., Sauter, G., Schlomm, T., et al. (2012) · Apmis · doi:10.1111/j.1600-0463.2012.02924.x · Cited by 87

A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression

Simons, B. W., Durham, N. M., Bruno, T. C., Grosso, J. F., Schaeffer, A. J., Ross, A. E., Hurley, P. J., Berman, D. M., Drake, C. G., Thumbikat, P., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4472 · Cited by 87

A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts

Platz, E. A., Kulaç, İ., Barber, J. R., Drake, C. G., Joshu, C. E., Nelson, W. G., Lucia, M. S., Klein, E. A., Lippman, S. M., Parnes, H. L., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0503 · Cited by 87

Discovery of a Novel Seminal Fluid Microbiome and Influence of Estrogen Receptor Alpha Genetic Status

Javurek, A. B., Spollen, W. G., Ali, A. M. M., Johnson, S., Lubahn, D. B., Bivens, N. J., Bromert, K. H., Ellersieck, M. R., Givan, S. A., & Rosenfeld, C. S. (2016) · Scientific Reports · doi:10.1038/srep23027 · Cited by 84

The prognostic impact of M‐CSF, CSF‐1 receptor, CD68 and CD3 in prostatic carcinoma

Richardsen, E. H., Uglehus, R. D., Due, J., Busch, C., & Busund, L.-T. R. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03058.x · Cited by 82

Plasma Antibodies against Chlamydia trachomatis, Human Papillomavirus, and Human Herpesvirus Type 8 in Relation to Prostate Cancer: A Prospective Study

Sutcliffe, S. S., Giovannucci, E. L., Gaydos, C. A., Viscidi, R. P., Jenkins, F. J., Zenilman, J. M., Jacobson, L. P., Marzo, A. M. D., Willett, W. C., & Platz, E. A. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0134 · Cited by 80

Sexually Transmitted Infections and Risk of Prostate Cancer: Review of Historical and Emerging Hypotheses

Sutcliffe, S. (2010) · Future Oncology · doi:10.2217/fon.10.95 · Cited by 75

Expression of Toll‐like receptor 4 in the prostate gland and its association with the severity of prostate cancer

Gatti, G., Quintar, A. A., Andreani, V., Nicola, J. P., Maldonado, C. A., Masini-Repiso, A. M., Rivero, V. E., & Maccioni, M. (2009) · The Prostate · doi:10.1002/pros.20984 · Cited by 61

Low Intratumoral Mast Cells Are Associated With a Higher Risk of Prostate Cancer Recurrence: Mast Cells and Prostate Cancer Recurrence

Hempel, H. A., Cuka, N. S., Kulac, I., Barber, J. R., Cornish, T. C., Platz, E. A., De Marzo, A. M., & Sfanos, K. S. (2017) · The Prostate · doi:10.1002/pros.23280 · Cited by 61

Acute Escherichia coli Prostatitis in Previously Health Young Men: Bacterial Virulence Factors, Antimicrobial Resistance, and Clinical Outcomes

Krieger, J. N., Dobrindt, U., Riley, D. E., & Oswald, É. (2011) · Urology · doi:10.1016/j.urology.2010.12.059 · Cited by 59

Immunohistochemical Analysis of Inflammatory Cells in Benign and Precancerous Lesions and Carcinoma of the Prostate

Fujii, T., Shimada, K., Asai, O., Tanaka, N., Fujimoto, K., Hirao, K., & Konishi, N. (2013) · Pathobiology · doi:10.1159/000342396 · Cited by 57

Thirty years of research on infection and prostate cancer: No conclusive evidence for a link. A systematic review

Hrbacek, J., Urban, M., Hamšíková, E., Tachezy, R., & Heráček, J. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.01.013 · Cited by 53

Chronic Prostatic Infection and Inflammation by Propionibacterium acnes in a Rat Prostate Infection Model

Olsson, J., Drott, J. B., Laurantzon, L., Laurantzon, O., Bergh, A. R. J., & Elgh, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051434 · Cited by 47

An evaluation of PCR primer sets used for detection of Propionibacterium acnes in prostate tissue samples

Sfanos, K. S., & Isaacs, W. B. (2008) · The Prostate · doi:10.1002/pros.20820 · Cited by 44

Toll‐like receptors in prostate infection and cancer between bench and bedside

Gambara, G., Cesaris, P. D., Nunzio, C. D., Ziparo, E., Tubaro, A., Filippini, A., & Riccioli, A. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12055 · Cited by 32

Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab

Postow, M. A., Cardona, D. M., Taube, J. M., Anders, R. A., Taylor, C. R., Wolchok, J. D., Callahan, M. K., Curran, M. A., Lesokhin, A. M., Grosso, J. F., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-s1-o8 · Cited by 29

Proteolysis of Complement Factors iC3b and C5 by the Serine Protease Prostate-Specific Antigen in Prostatic Fluid and Seminal Plasma

Manning, M. L., Williams, S. A., Jelinek, C., Kostova, M. B., & Denmeade, S. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200856 · Cited by 28

Prostate Cancer Immunotherapy: Beyond Immunity to Curability

Simons, J. W. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0174 · Cited by 24

Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5- b ]Pyridine (PhIP)–Induced Cancer at Multiple Sites

Sfanos, K. S., Canene‐Adams, K., Hempel, H., Yu, S.-H., Simons, B. W., Schaeffer, A. J., Schaeffer, E. M., Nelson, W. G., & Marzo, A. M. D. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0090 · Cited by 24

Insight into infection‐mediated prostate damage: Contrasting patterns of C‐reactive protein and prostate‐specific antigen levels during infection

Milbrandt, M., Winter, A. C., Nevin, R. L., Pakpahan, R., Bradwin, G., Marzo, A. M. D., Elliott, D. J., Gaydos, C. A., Isaacs, W. B., Nelson, W. G., et al. (2017) · The Prostate · doi:10.1002/pros.23392 · Cited by 15

Intraepithelial lymphocytes in relation to NIH category IV prostatitis in autopsy prostate

Dikov, D., Bachurska, S. Y., Staikov, D., & Sarafian, V. S. (2015) · The Prostate · doi:10.1002/pros.22991 · Cited by 14

Drug-microbiota interactions: an emerging priority for precision medicine

Zhao, Q., Chen, Y., Huang, W., Zhou, H., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01619-w · Cited by 268

Flavonoids: A Myth or a Reality for Cancer Therapy?

Forni, C., Rossi, M., Borromeo, I., Feriotto, G., Platamone, G., Tabolacci, C., Mischiati, C., & Beninati, S. (2021) · Molecules · doi:10.3390/molecules26123583 · Cited by 79

Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression

Papachristodoulou, A., Heidegger, I., Virk, R. K., Di Bernardo, M., Kim, J. Y., Laplaca, C., Picech, F., Schäfer, G., De Castro, G. J., Hibshoosh, H., et al. (2024) · European Urology · doi:10.1016/j.eururo.2023.07.016 · Cited by 18